Fundraising Fox

Kytopen

Cambridge, US · Founded 2017 · Delaware corporation · 7 known investors

kytopen.com ↗

MIT spin-out offering a customizable multi-solution platform for discovery, development, and manufacturing of cell therapies using non-viral delivery technology.

Biotechin /kytopen

Founders & leadership

CB
Cullen BuieDirector
MC
Michael ChiuDirector, Executive Officer
PG
Paulo GarciaExecutive Officer, Director, Promoter
PM
Paxton MajorDirector
AD
Ann DeWittDirector
PW
Paul WottonDirector
JV
Julio VegaMr. Vega is the Secretary of the Issuer.

Investors · 7

Bantam GroupWestwood
Horizons VenturesHong Kong · $1M – $110M
MassVenturesWaltham · $250K – $500K
Selvedge VentureLondon
TBD AngelsNew York
Telegraph Hill PartnersSan Francisco · $2M – $8M
The Engine VenturesCambridge

Reported raises · per SEC filings

Form D private placements
▶$7.1MraisedFeb 2025 · 13 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Cullen BuieDirector
  • Julio VegaExecutive Officer
  • Michael ChiuDirector, Executive Officer
  • Paul WottonDirector
  • Paxton MajorDirector
Offering amount
$15M
Amount sold
$7.1M
First sale
Feb 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.7MraisedFeb 2024 · 22 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Paxton MajorDirector
  • Michael ChiuDirector, Executive Officer
  • Bethany GrantExecutive Officer
  • Edward FreedmanDirector
  • Cullen BuieDirector
  • Paul WottonDirector
Offering amount
$8M
Amount sold
$5.7M
First sale
Jan 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$32.5MraisedOct 2021 · 18 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Adam WieschhausDirector
  • Paulo GarciaExecutive Officer, Director, Promoter
  • Theresa TribbleDirector
  • Cullen BuieDirector
Offering amount
$32.5M
Amount sold
$32.5M
First sale
Sep 2021
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.1MraisedNov 2020 · 11 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ann DeWittDirector
  • Paulo GarciaExecutive Officer, Director, Promoter
  • Cullen BuieDirector
Offering amount
$4M
Amount sold
$3.1M
First sale
Oct 2020
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.3MraisedMay 2019 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Paulo GarciaExecutive Officer, Director, Promoter
  • Julio VegaExecutive Officer
  • Cullen BuieDirector
  • Ann DeWittDirector
Offering amount
$4.3M
Amount sold
$4.3M
First sale
May 2019
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.